![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HELZ2 |
Gene summary for HELZ2 |
![]() |
Gene information | Species | Human | Gene symbol | HELZ2 | Gene ID | 85441 |
Gene name | helicase with zinc finger 2 | |
Gene Alias | PDIP-1 | |
Cytomap | 20q13.33 | |
Gene Type | protein-coding | GO ID | GO:0000184 | UniProtAcc | Q9BYK8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
85441 | HELZ2 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.62e-02 | 1.28e-01 | -0.1464 |
85441 | HELZ2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 7.15e-04 | 1.21e-01 | -0.059 |
85441 | HELZ2 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.19e-08 | 2.33e-01 | 0.096 |
85441 | HELZ2 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.33e-05 | 1.76e-01 | 0.0338 |
85441 | HELZ2 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.17e-14 | 5.33e-01 | 0.3859 |
85441 | HELZ2 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.16e-10 | 7.15e-01 | 0.2585 |
85441 | HELZ2 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 8.78e-10 | 3.68e-01 | 0.3005 |
85441 | HELZ2 | LZE20T | Human | Esophagus | ESCC | 1.97e-05 | 2.79e-01 | 0.0662 |
85441 | HELZ2 | LZE24T | Human | Esophagus | ESCC | 2.92e-15 | 5.29e-01 | 0.0596 |
85441 | HELZ2 | LZE21T | Human | Esophagus | ESCC | 2.39e-05 | 3.01e-01 | 0.0655 |
85441 | HELZ2 | P1T-E | Human | Esophagus | ESCC | 1.64e-06 | 5.71e-01 | 0.0875 |
85441 | HELZ2 | P2T-E | Human | Esophagus | ESCC | 1.63e-10 | 2.58e-01 | 0.1177 |
85441 | HELZ2 | P4T-E | Human | Esophagus | ESCC | 1.39e-02 | 1.07e-01 | 0.1323 |
85441 | HELZ2 | P5T-E | Human | Esophagus | ESCC | 1.01e-08 | 1.26e-01 | 0.1327 |
85441 | HELZ2 | P8T-E | Human | Esophagus | ESCC | 2.35e-03 | 1.06e-01 | 0.0889 |
85441 | HELZ2 | P9T-E | Human | Esophagus | ESCC | 2.08e-07 | 2.04e-01 | 0.1131 |
85441 | HELZ2 | P10T-E | Human | Esophagus | ESCC | 1.20e-02 | 3.49e-02 | 0.116 |
85441 | HELZ2 | P11T-E | Human | Esophagus | ESCC | 1.51e-20 | 6.73e-01 | 0.1426 |
85441 | HELZ2 | P12T-E | Human | Esophagus | ESCC | 1.32e-04 | 1.26e-01 | 0.1122 |
85441 | HELZ2 | P17T-E | Human | Esophagus | ESCC | 3.65e-08 | 5.79e-01 | 0.1278 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006401 | Colorectum | AD | RNA catabolic process | 102/3918 | 278/18723 | 8.64e-10 | 6.76e-08 | 102 |
GO:0044270 | Colorectum | AD | cellular nitrogen compound catabolic process | 147/3918 | 451/18723 | 3.35e-09 | 2.23e-07 | 147 |
GO:0046700 | Colorectum | AD | heterocycle catabolic process | 145/3918 | 445/18723 | 4.37e-09 | 2.84e-07 | 145 |
GO:0006402 | Colorectum | AD | mRNA catabolic process | 87/3918 | 232/18723 | 4.40e-09 | 2.84e-07 | 87 |
GO:0034655 | Colorectum | AD | nucleobase-containing compound catabolic process | 133/3918 | 407/18723 | 1.56e-08 | 9.12e-07 | 133 |
GO:0019439 | Colorectum | AD | aromatic compound catabolic process | 146/3918 | 467/18723 | 7.48e-08 | 3.84e-06 | 146 |
GO:1901361 | Colorectum | AD | organic cyclic compound catabolic process | 153/3918 | 495/18723 | 8.23e-08 | 4.18e-06 | 153 |
GO:0000956 | Colorectum | AD | nuclear-transcribed mRNA catabolic process | 40/3918 | 112/18723 | 2.11e-04 | 2.79e-03 | 40 |
GO:00064012 | Colorectum | MSS | RNA catabolic process | 102/3467 | 278/18723 | 5.07e-13 | 1.02e-10 | 102 |
GO:00064022 | Colorectum | MSS | mRNA catabolic process | 89/3467 | 232/18723 | 8.70e-13 | 1.60e-10 | 89 |
GO:00442702 | Colorectum | MSS | cellular nitrogen compound catabolic process | 141/3467 | 451/18723 | 2.95e-11 | 3.83e-09 | 141 |
GO:00467002 | Colorectum | MSS | heterocycle catabolic process | 139/3467 | 445/18723 | 4.37e-11 | 5.05e-09 | 139 |
GO:00346552 | Colorectum | MSS | nucleobase-containing compound catabolic process | 129/3467 | 407/18723 | 7.48e-11 | 8.18e-09 | 129 |
GO:19013612 | Colorectum | MSS | organic cyclic compound catabolic process | 148/3467 | 495/18723 | 3.47e-10 | 3.18e-08 | 148 |
GO:00194392 | Colorectum | MSS | aromatic compound catabolic process | 140/3467 | 467/18723 | 8.56e-10 | 6.85e-08 | 140 |
GO:00009561 | Colorectum | MSS | nuclear-transcribed mRNA catabolic process | 42/3467 | 112/18723 | 1.75e-06 | 5.60e-05 | 42 |
GO:0000184 | Colorectum | MSS | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 15/3467 | 37/18723 | 1.51e-03 | 1.39e-02 | 15 |
GO:0006401110 | Esophagus | ESCC | RNA catabolic process | 204/8552 | 278/18723 | 3.39e-21 | 5.66e-19 | 204 |
GO:0034655110 | Esophagus | ESCC | nucleobase-containing compound catabolic process | 272/8552 | 407/18723 | 2.92e-18 | 2.90e-16 | 272 |
GO:0006402110 | Esophagus | ESCC | mRNA catabolic process | 170/8552 | 232/18723 | 8.70e-18 | 8.00e-16 | 170 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HELZ2 | SNV | Missense_Mutation | c.2156N>A | p.Arg719His | p.R719H | Q9BYK8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
HELZ2 | SNV | Missense_Mutation | c.253N>A | p.Leu85Ile | p.L85I | Q9BYK8 | protein_coding | deleterious(0.01) | possibly_damaging(0.746) | TCGA-AZ-6601-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
HELZ2 | SNV | Missense_Mutation | c.2006C>T | p.Ala669Val | p.A669V | Q9BYK8 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-CA-6719-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
HELZ2 | SNV | Missense_Mutation | rs573248815 | c.7576N>A | p.Ala2526Thr | p.A2526T | Q9BYK8 | protein_coding | deleterious(0.01) | probably_damaging(0.995) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
HELZ2 | SNV | Missense_Mutation | rs768418245 | c.3746N>A | p.Arg1249His | p.R1249H | Q9BYK8 | protein_coding | tolerated(0.1) | benign(0.003) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
HELZ2 | SNV | Missense_Mutation | c.4048N>T | p.Ala1350Ser | p.A1350S | Q9BYK8 | protein_coding | tolerated(0.31) | possibly_damaging(0.571) | TCGA-CM-5341-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | fluorouracil | SD | |
HELZ2 | SNV | Missense_Mutation | c.4936G>A | p.Ala1646Thr | p.A1646T | Q9BYK8 | protein_coding | tolerated(0.29) | benign(0.229) | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
HELZ2 | SNV | Missense_Mutation | rs776067170 | c.4846N>A | p.Glu1616Lys | p.E1616K | Q9BYK8 | protein_coding | tolerated(0.91) | benign(0.051) | TCGA-CM-6162-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | oxaliplatin | SD |
HELZ2 | SNV | Missense_Mutation | rs375422831 | c.5956N>A | p.Ala1986Thr | p.A1986T | Q9BYK8 | protein_coding | tolerated(1) | benign(0.001) | TCGA-CM-6674-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
HELZ2 | SNV | Missense_Mutation | c.1755N>T | p.Glu585Asp | p.E585D | Q9BYK8 | protein_coding | tolerated(0.08) | possibly_damaging(0.823) | TCGA-CM-6676-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |